Clinical Trials
2 trialsNCT00984542 2014-03-12
Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00168922 2006-04-27
Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Charite University, Berlin, Germany
Phase 2 Unknown